Calcium-independent tacrine-induced relaxation of rat gastric corpus smooth muscles

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 11, 2006, Pages 1133-1138

  Krustev, Atanas D ^a   Argirova, Mariana D ^a   Getova, Damianka P ^a   Turiiski, Valentin I ^a   Prissadova, Natalia A ^a  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

Author keywords

Ca2+ desensitization; Gastric smooth muscle; Tacrine

Indexed keywords

APAMIN; ATROPINE; CAFFEINE; CALCIUM; CHARYBDOTOXIN; GALLOPAMIL; IPRATROPIUM BROMIDE; METRIFONATE; NIFEDIPINE; TACRINE; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL PERMEABILIZATION; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH MUSCLE;

ACETYLCHOLINE; ANIMALS; CAFFEINE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; RATS; SODIUM; SODIUM CHANNEL BLOCKERS; STOMACH; TACRINE; TIME FACTORS;

EID: 33947520919     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-059     Document Type: Article

References (28)

1. Allal, C., Lazartigues, E., Tran, M.A., Brefel-Courbon, C., Gharib, C., Montastruc, J.L., and Rascol, O. 1998. Central cardiovascular effects of tacrine in the conscious dog, a role for catecholamines and vasopressin release. Eur. J. Pharmacol. 348: 191-198. doi:10.1016/S0014-2999(98)00143-5.
2. 2+](i) during refilling in bovine airway smooth muscle cells. Arch. Med. Res. 31: 558-563. doi:10.1016/S0188- 4409(00)00156-9.
3. Becerra, M.A., Herera, M.D., and Marhuenda, E. 2001. Action of tacrine on muscarinic receptors in rat intestinal smooth muscle. J. Auton. Pharmacol. 21: 113-119. doi:10.1046/j.1365-2680. 2001.00213.x.
4. Bonner, L.T., and Peskind, E.R. 2002. Pharmacologic treatments of dementia. Med. Clin. North Am. 86: 657-674. doi:10.1016/S0025-7125(02) 00007-X.
5. Burov, Yu.V., Drozdova, E.I., Pivovarov, A.S., and Robakidze, T.N. 1994. Amiridin and tacrine modulation of the activity and plasticity of the cholinoreceptors of neurons of the common snail, phenomenology and mechanisms. Neurosci. Behav. Physiol. 24: 507-512. doi:10.1007/BF02360176.
6. Colombres, M., Sagal, J.P., and Inestrosa, N.C. 2004. An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds. Curr. Pharm. Des. 10: 3121-3130.
7. Crismon, M.L. 1998. Pharmacokinetics and drug interaction of cholinesterase inhibitors administered in Alzheimer's disease. Pharmacotherapy, 18: 47-54.
8. D'Angelo, E., De Filippi, G., Rossi, P., and Taglietti, V. 1998. Ionic mechanism of electroresponsiveness in cerebellar granule cells implicates the action of a persistent sodium current. J. Neurophysiol. 80: 493-503.
9. Dolezal, V., Lisa, V., and Tucek, S. 1997. Effect of tacrine on intracellular calcium in cholinergic SN56 neuronal cells. Brain Res. 769: 219-224. doi:10.1016/S0006-8993(97) 00711-7.
10. Eboue, D., Auger, R., Angiari, C., Le Doan, T., and Tenu, J.P. 2003. Use of a simple fractionation method to evaluate binding, internalization and intracellular distribution of oligonucleotides in vascular smooth muscle cells. Arch. Physiol. Biochem. 111: 265-272. doi:10.1076/apab.111.3.265.23465.
11. Gibson, G.E., and Manger, T. 1988. Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine. Biochem. Pharmacol. 37: 4191-4196. doi:10.1016/0006-2952(88)90115-3.
12. Grutzendler, J., and Morris, J.S. 2001. Cholinesterase inhibitors for Alzheimer's disease. Drugs, 61: 41-52. doi:10.2165/00003495-200161010- 00005.
13. Jarlebark, L., and Heilbronn, E. 1992. Tetrahydroaminoacridine and related compounds interfere with fura-2 and indo-1. Eur. J. Pharmacol. 225: 75-77.
14. Li, C.Y., Wang, H., Xue, H., Carrier, P.R., Hui, K.M., Pang, Y.P., Li, Z.W., and Han, Y.F. 1999. Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist. Neuroreport, 10: 795-800.
15. Nakajima, T., Ma, J., Iida, H., Iwasawa, K., Jo, T., Omata, M., and Nagai, R. 2003. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells. Jpn. Heart J. 44: 963-978. doi:10.1536/jhj.44.963.
16. Ott, B.R. 2002. Medical treatment of Alzheimer's disease, past, present, and future. Med. Health R. I. 85: 210-212.
17. Rustichelli, C., Gamberini, M.C., Ferioli, V., and Gamberini, G. 1999. Properties of the racemic species of verapamil hydrochloride and gallopamil hydrochloride. Int. J. Pharm. 178: 111-120. doi:10.1016/S0378-5173(98) 00355-X.
18. Sah, V.P., Seasholtz, T.M., Sagi, S.A., and Brown, J.H. 2000. The role of Rho in G-protein-coupled signal transduction. Annu. Rev. Pharmacol. Toxicol. 40: 459-489. doi:10.1146/annurev.pharmtox.40.1.459.
19. Scali, C., Casamenti, F., Bellucci, A., Costagli, C., Schmidt, B., and Pepeu, G. 2002. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. J. Neural Transm. 109: 1067-1080. doi:10.1007/s007020200090.
20. Somlyo, A.P., and Somlyo, A.V. 2000. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. 522: 177-185. doi:10.1111/j.1469-7793.2000.t01-2-00177.x.
21. Somlyo, A.V., Bond, M., Somlyo, A.P., and Scarpa, A. 1985. Inositol triphosphate-induced calcium release and contraction in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A. 82: 5231-5235. doi:10.1073/pnas.82.15.5231.
22. Spassov, V., Krustev, A., Turijski, V., and Getova-Spassova, D. 2002. Influence of anticholinesterase drug on mechanical activity of isolated vascular smooth muscle and gastric strips (abstract of the 15th Congress of the European College of Neuropsychopharmacology, Barcelona, Spain, October 5-9, 2002). Eur. Neuropsychopharmacol. 12(Suppl. 3): 369. doi:10.1016/S0924-977X(02)80599- 5.
23. 2+ stores in sarcoplasmic reticulum isolated from arterial and gastric smooth muscle. Can. J. Physiol. Pharmacol. 80: 588-603. doi:10.1139/y02-083.
24. Turijski, V., Krustev, A., Getova-Spassova, D., and Spassov, V. 2004. Influence of tacrine on dopamine-induced reactions of the gastric smooth muscle of rats. Methods Find. Exp. Clin. Pharmacol. 26: 103-107. doi:10.1358/mf.2004.26.2.800062.
25. Turiiski, V.I., Argirova, M.D., and Krastev, A.D. 2005. Non-anticholinesterase, non-cholinergic effect of tacrine on gastrointestinal smooth muscle tissues of rat. Folia Med. (Plovdiv), 47: 45-51.
26. Warpman, U., Zhang, X., and Nordberg, A. 1996. Effect of tacrine on in vivo release of dopamine and its metabolites in the striatum of freely moving dats. J. Pharmacol. Exp. Ther. 277: 917-922.
27. Wu, X., Haystead, T.A.J., Nakamoto, R.K., Somlio, A.V., and Somlio, A.P. 1998. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. J. Biol. Chem. 273: 11362-11365. doi:10.1074/jbc.273.18.11362.
28. 2+ release in a feedback regulation of pyramidal cell excitability. J. Neurophysiol. 91: 2322-2329.